DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20211028

Prescription pattern study of antiasthmatics drugs in tertiary care centre

Ujwala P. Gawali, Parmeshwar B. Gholve, Salman H. Rizvi, Prashant S. Mishra

Abstract


Background: Bronchial asthma is a social and economic healthcare burden. Drug Utilization studies can play a key role in helping the healthcare system to understand, interpret and improve the prescribing administration & use of medications.

Methods: A prospective, Cross-sectional, Observational study was conducted at inpatient and outpatient Department of Medicine and Paediatrics in tertiary health care centre. As per inclusion criteria, 127 patients with asthma were interviewed, and prescription data was recorded in a pre-designed case record form from 1 October 2018 to 31 December 2018.

Results: A total of 127 prescriptions were studied. It was observed that majority of the study patients were in the age group of 40-50 years, with 83 (65.5%) males and 44 (34.6%) females. Most of the patients were of Mild intermittent asthma 65 (51.18 %) followed by patients with Mild persistent asthma 31 (24.40 %). 10 different anti-asthmatics drugs were prescribed along with adjunctive medicines. Most of the patients received multiple drug therapy 98 (77.16 %). Prevalence of two drug combination was the highest 74 (58.26 %) followed by monotherapy29 (22.83 %). Most common route of drug administration was inhalational route followed by oral route. β2 agonists and corticosteroids were the most commonly prescribed combination drugs followed by methylxanthines. 103 (81.10 %) prescription contains both generic and brand drugs compared to generic names only 16 (12.59 %) and brand names only 8 (6.29 %).

Conclusions: This study concluded that the present prescribing practice in asthma therapy in tertiary care centre is not sufficiently rational. Hence, it is necessary to encourage physicians to follow asthma guidelines while managing asthmatic patients.


Keywords


Prescription pattern, Brochial asthma, Beta-2 agonist, Corticosteroids

Full Text:

PDF

References


Global initiative for asthma. Global Strategy for Asthma Management and Prevention, 2017. Available from: www.ginasthma.org. Last accessed on

Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009;64(6):476-83.

Rafeeq MM, Murad H. Evaluation of drug utilization pattern for patients of bronchial asthma in a government hospital of Saudi Arabia. Niger J Clin Pract. 2017;20(9):1098-1105.

Pandey A, Tripathi P, Pandey RD. Prescription pattern in asthma therapy at Gorakhpur hospitals. Lung India. 2010;27(1):8-10.

Fernandes L, Henry PJ, Goldie RG. β-Adrenoceptor Agonists. In: Page CP, Barnes PJ, editors. Handbook of Experimental Pharmacology. Berlin: Springer. 2004;4-35.

Yawn BP. Factors accounting for asthma variability: achieving optimal symptom control for individual patients. Prim Care Respir J. 2008;17(3):138-47.

D.P. Pinal, R.K. Patel, N.J. Patel, Analysis of prescription pattern and drug utilization in asthma therapy, IRJP. 2012;7(3):257-260.

Sun HL, Kao KH, Chou MC, Lu TH, Lue KH. Differences in the prescription patterns of anti-asthmatic medications for children by paediatricians, family physicians and physicians of other specialties. J Formos Med Assoc. 2006;105(6):277-283.

Jain S, Upadhyaya P, Goyal J. A systematic review of prescription pattern monitoring studies and their effectiveness in promoting rational use of medicines. Perspect Clin Res. 2015;6(2):86-90.

Db J, Vijay P, Yakaiah V, Ambadasu B. A Prospective Study on Prescription Pattern in Chronic Obstructive Pulmonary Disease. Maedica (Bucur). 2020;15(1):37-44.

National Heart, Lung, and Blood Institute, National Institutes of Health. International Consensus Report on the Diagnosis and Treatment of Asthma. Bethesda: National Heart, Lung, and Blood Institute, National Institutes of Health. 1992;92-3091.

National Heart Lung and Blood institute and WHO Global Strategy for Asthma management and prevention. NHLBI/WHO workshop. NIH Publication no. 974051, Bethesda M D.USA: 1997.

Ungar WJ, Coyte PC. Prospective study of the patient level cost of asthma care in children. Pediatr Pulmonol. 2001;32:101-8.

Shimpi RD, Salunkhe PS, Bavaskar SR, Laddha GP, Kalam A, Patel KH. Drug utilization evaluation and prescription monitoring In asthmatic patients. Int J Pharm Biolog Sci. 2012;2:117-22.

Kumar A, Tiwari HK, Kulkarni SK. Drug utilization assessment in asthma therapy through prescription monitoring. IJHP. 2004;41:70-2.

Srivastava R, Sharma S, Keshri L, Wal P. Assessment of prescription pattern in asthma therapy at Shamli hospitals. Rev Recent Clin Trials. 2012;7(2):158-64.

NIH. Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Institutes of Health (NIH). 1997;41:4051-4097.

Ip M, Lam K, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994;105:1722-7.